期刊文献+

p14ARF经p53凋亡通路增强骨肉瘤U2OS细胞对顺铂的敏感性 被引量:1

p14ARF enhances chemosensitivity to cisplatin in human osteosarcoma U2OS cells through p53 apoptotic pathway
原文传递
导出
摘要 目的 探讨抑癌基因p14ARF增强骨肉瘤U2OS细胞对顺铂的敏感性及其作用机制.方法 使用顺铂处理不表达p14ARF的U2OS细胞和稳定表达p14ARF的U2OS-ARF细胞,采用噻唑蓝(MTT)比色法测定细胞毒作用和半数抑制浓度值;流式细胞术和Hoechst 33258荧光染色检测细胞凋亡;免疫印迹法检测p53以及其下游基因Bax、p21、Mdm2、Fas的表达;比色法检测半胱氨酸天门冬氨酸蛋白酶(caspase)-3、caspase-8、caspase-9蛋白酶的活性.结果 顺铂处理72 h后,U2OS、U2OS-vec和U2OS-ARF组的细胞活力分别为(84.8%±4.4%)、(86.9%±5.0%)和(66.7%±4.6%),相比U2OS-ARF的细胞活力明显降低,U2OS、U2OS-vec和U2OS-ARF组的IC50分别为(15.8±0.9)、(16.3±0.6)μmol/L和(8.9±0.8)μmol/L,相比U2OS-ARF的IC50明显降低(P<0.05).流式细胞术和形态学鉴定表明相对于U2OS和U2OS-vec细胞,U2OS-ARF细胞表现更为明显的凋亡比例和凋亡特异性形态学变化.在U2OS-ARF细胞中,p53、Mdm2和p21的基础表达水平稍稍高于U2OS-vec对照细胞,顺铂处理在U2OS-vec和U2OS-ARF细胞均明显激活p53、Mdm2和p21的表达,但在U2OS-ARF细胞中更加明显;另外,顺铂处理对U2OS-vec细胞中Bax和Fas的表达没有影响,却在U2OS-ARF细胞中明显增强了Bax的表达,但对Fas无影响.p14ARF还增强顺铂对caspase-9和caspase-3的活化.结论 p14ARF通过p53凋亡通路增强骨肉瘤U2OS细胞对顺铂的敏感性,并与内源性线粒体通路有关. Objective To explore the effects of tumor suppressor p14ARF on chemosensitivity of human osteosarcoma U2OS cells to cisplatin and elucidate its molecular mechanism.Methods U2OS cells expressing no p14ARF and U2OS-ARF cells expressing p14ARF stably through stable transfection were treated with cisplatin.Cell viability and IC50 were assayed with methyl thiazolyl tetrazolium (MTT).Apoptosis was examined by fluorescence-activated cell sorting and Hoechst33258 staining.The expressions of p53,Bax,p21,Mdm2 and Fas were detected by Western blot.And colorimetry was used to determine the activities of caspase-3,caspase-8 and caspase-9.Results The viability was 84.8% ± 4.4%,86.9% ± 5.0% and 66.7% ±4.6% respectively in U2OS,U2OS-vec and U2OS-ARF cells.The values of IC50 were (15.8 ± 0.9) μmol/L,(16.3 ± 0.6) and (8.9 ± 0.8) μmol/L respectively in U2OS,U2OS-vec and U2OS-ARF cells.The levels of viability and IC50 obviously decreased in U2OS-ARF cells in response to cisplatin (P 〈 0.05).There were higher apoptotic rate and more obvious apoptotic morphological changes in U2OS-ARF cells than U2OS and U2OS-vec cells.The basal levels of p53,Mdm2 and p21 in U2OS-ARF cells were slightly higher than those in U2OS-vec cells.Cisplatin up-regulated p53,Mdm2 and p21 in both cell lines.However,the up-regulation was more pronounced in U2OS-ARF cells.Cisplatin did not change the levels of Bax and Fas in U2OS-vec cells.Bax protein was up-regulated in U2OS-ARF cells while the level of Fas remained constant,p14ARF also enhanced the activities of caspase-9 and caspase-3 in response to cisplatin.Conclusion p14ARF enhances the chemosensitivity to cisplatin in human osteosarcoma U2OS cells through p53 apoptotic pathway.And intrinsic mitochondrial apoptosis is involved.
出处 《中华医学杂志》 CAS CSCD 北大核心 2014年第43期3443-3446,共4页 National Medical Journal of China
基金 广东省医学科研基金(B2009249 A2013755)
关键词 骨肉瘤 顺铂 药物疗法 联合 蛋白质P53 P14ARF Osteosarcoma Cisplatin Drug therapy, combination Protein p53 p14ARF
  • 相关文献

参考文献13

  • 1Botter SM, Neri D, Fuchs B. Recent advances in osteosarcoma [J]. Curr Opin Pharmaeol, 2014, 16: 15-23.
  • 2Mao L, Merlo A, Bedi G, et al. A novel pl6INK4A transcript [J]. Cancer Res, 1995, 559: 2995-2997.
  • 3Oh JH, Kim HS, Kim HH, et al. Aberrant methylation of pl4ARF gene correlates with poor survival in osteosarcoma [ J ]. Clin Orthop Relat Res, 2006, 442: 216-222.
  • 4Ozenne P, Eymin B, Brambilla E, et al. The ARF tumor suppressor: structure, functions and status in cancer [J ]. Int J Cancer, 2010, 127: 2239-2247.
  • 5Park YB, Park MJ, Kimura K, et al. Alterations in the INK4a/ ARF locus and their effects on the growth of human osteosarcoma cell lines[J]. Cancer Genet Cytogenet, 2002, 133: 105-111.
  • 6原向伟,廖威明,黄秀芳,梁胜根,陈忠羡,范全,秦英,朱孝峰.p14ARF增强顺铂诱导的骨肉瘤U2OS细胞凋亡的研究[J].中华关节外科杂志(电子版),2010,4(6):50-53. 被引量:3
  • 7A1-Mohanna MA, Manogaran PS, A1-Mukhalafi Z, et al. The tumor suppressor p16 (INK4a) gene is a regulator of apoptosis induced by uhraviolet light and cisplatin [ J ]. Oncogene, 2004, 23 : 201-212.
  • 8Gill J, Ahluwalia MK, Geller D, et al. New targets and approaches in osteosareoma[J]. Pharmacol Ther, 2013, 137: 89-99.
  • 9Jung YS, Lee SJ, Lee SH, et al. Loss of VHL promotes progerin expression, leading to impaired pl4/ARF function and suppression of p53 activity[J]. Cell Cycle, 2013, 12: 2277-2290.
  • 10Kolenko VM, Uzzo RG, Bukowski R, et al. Caspase-dependent and -independent death pathways in cancer therapy [ J ]. Apoptosis, 2000, 5 : 17-20.

二级参考文献14

  • 1Mao L, Medo A, Bedi G, et al. A novel p16INK4A transcript. Cancer Res, 1995, 55 (14) : 2995 -2997.
  • 2Quene DE, Zindy F, Ashmun RA, et al, Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell, 1995, 83 (6) : 993 - 1000.
  • 3de Stanchina E, McCurrach ME, Zindy F, et al. E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev, 1998, 12 (15) : 2434 -2442.
  • 4Guo-Chang F, Chu-Tse W. Transfer of p14ARF gene in drugresistant human breast MCF-7/Adr cells inhibits proliferation and reduces doxorubicin resistance. Cancer Lett, 2000, 158 (2) : 203 -210.
  • 5Park YB, Park MJ, Kimura K, et al. Alterations in the INK4a/ ARF locus and their effects on the growth of human osteosarcoma cell lines. Cancer Genet Cytogenet, 2002, 133 (2): 105- 111.
  • 6Sheer CJ. Autophagy by ARF : a short story. Mol Cell, 2006, 22 : 436 - 437.
  • 7Oh JH, Kim HS, Kim HH, et al. Aberrant methylation of p14ARF gene correlates with poor survival in osteosarcoma. Clin Orthop Relat Res, 2006(442) : 216 -222.
  • 8Hemmati PG, Gillissen B, von Haefen C, et al. Adenovirusmediated overexpression of p14 ( ARF ) induces p53 and Baxindependent apoptosis. Oncogene, 2002, 21 (20) : 3149 - 3161.
  • 9Gallagher S, Kefford RF, Rizos H. Enforced expression of p14ARF induces p53-depeodent cell cycle arrest but not apoptosis. Cell Cycle, 2005, 4 (3) : 465 - 472.
  • 10Saraste A. Morphologic criteria and detection of apoptosis. Herz, 1999, 24 (3) : 189 - 195.

共引文献2

同被引文献15

  • 1Botter SM, Neri D, Fuchs B. Recent advances in osteosarcoma [J]. Curr Opin Pharmacol, 2014, 16C:15-23.
  • 2Ozenne P, Eymin B, Brambilla E, et al. The ARF tumor suppressor:structure, functions and status in cancer [ J]. Int J Cancer, 2010, 127(10) :2239-2247.
  • 3Park YB, Park MJ, Kimura K, et al. Alterations in the INK4a/ ARF locus and their effects on the growth of human osteosarcoma cell lines[J]. Cancer Genet Cytogenet, 2002, 133(2) :105-111.
  • 4Jung YS, Lee SJ, Lee SH, et al. Loss of VHL promotes progerin expression, leading to impaired pl4/ARF function and suppression of p53 activity[J]. Cell Cycle,2013,12(14) :2277-2290.
  • 5Oh JH, Kim HS, Kim HH,et al. Aberrant methylation of pl4ARF gene correlates with poor survival in osteosarcoma[ J]. Clin Orthop Relat Res, 2006, 442:216-222.
  • 6Mac L, Merlo A, Bedi G, et al. A novel pl6INK4A transcript[J]. Cancer Res, 1995, 559(14) :2995-2997.
  • 7Hollstein M, Sidransky D, Vogelstein B, et al. p53 mutations in human cancers[J]. Science, 1991,253 (5015) :49-53.
  • 8Muller M, Schleithoff ES, Stremmel W, et al. One, two, three- 1:63, p63, p73 and chemosensitivity. Drug Resist Updat ,2006, 9 (6) :288-306.
  • 9Gill J, Ahluwalia MK, Geller D, et al. New targets and approaches in osteosarcoma[ J]. Pharmacol Ther, 2013, 137( 1 ) :89-99.
  • 10Sherr CJ, Weber JD. The ARF/p53 pathway[J]. Curr Opin Genet Dev ,2000,10 (1) :94-99.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部